NCT01666041View on ClinicalTrials.gov

Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

July 31, 2013

Conditions
Hypertriglyceridemia
Interventions
DRUG

placebo

DRUG

fenofibrate/omega

DRUG

fenofibrate

Trial Locations (1)

405-760

Gil Medical Center, Incheon

All Listed Sponsors
lead

Gachon University Gil Medical Center

OTHER

NCT01666041 - Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate | Biotech Hunter | Biotech Hunter